Myocardial B cells are a subset of circulating lymphocytes with delayed transit through the heart

Luigi, Adamo, Cibele, Rocha-Resende, Chieh-Yu, Lin, Sarah, Evans, Jesse, Williams, Hao, Dun, Wenjun, Li, Cedric, Mpoy, Prabhakar S., Andhey, Buck E., Rogers, Kory, Lavine, Daniel, Kreisel, Maxim, Artyomov, Gwendalyn J., Randolph, Douglas L., Mann

JCI Insight |

Current models of B lymphocyte biology posit that B cells continuously recirculate between lymphoid organs without accumulating in peripheral healthy tissues. Nevertheless, B lymphocytes are one of the most prevalent leukocyte populations in the naive murine heart. To investigate this apparent inconsistency in the literature, we conducted a systematic analysis of myocardial B cell ontogeny, trafficking dynamics, histology, and gene expression patterns. We found that myocardial B cells represent a subpopulation of circulating B cells that make close contact with the microvascular endothelium of the heart and arrest their transit as they pass through the heart. The vast majority (> 95%) of myocardial B cells remain intravascular, whereas few (< 5%) myocardial B cells cross the endothelium into myocardial tissue. Analyses of mice with B cell deficiency or depletion indicated that B cells modulate the myocardial leukocyte pool composition. Analysis of B cell deficient animals suggested that B cells modulate myocardial growth and contractility. These results transform our current understanding of B cell recirculation in the naive state and reveal a previously unknown relationship between B cells and myocardial physiology. Further work will be needed to assess the relevance of these findings to other organs.